23andMe Holding Co.
Change company Symbol lookup
Select an option...
ME 23andMe Holding Co.
UZAPF Flughafen Zuerich AG
SLVO Credit Suisse X-Links Silver Shares Covered Call ETN
ARQQ Arqit Quantum Inc
MA Mastercard Inc
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
PSNL Personalis Inc
CORR CorEnergy Infrastructure Trust Inc
SBRA Sabra Health Care REIT Inc
Go

Company profile

23andMe Holding Co., formerly VG Acquisition Corp., is a consumer genetics and research company. The Company offers direct-to-consumer genetic testing and personalized information about genetic health risks, ancestry, and traits. The Company operates through two segments: Consumer & Research Services and Therapeutics. Its consumer & research services business segment comprises personal genome service (PGS) and research services. Its PGS provides a suite of genetic reports, including information on genetic ancestral origins, personal genetic health risks, rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Company’s therapeutics segment focuses on drug development for discovering and developing therapies to improve patient lives and includes out-licensing of intellectual property. The Company’s programs across therapeutic areas, include oncology, immunology, neurology, metabolic and cardiovascular diseases.

Postmarket

Last Trade
Delayed
$4.81
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.81
Day's Change
-0.03 (-0.62%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
5.06
Day's Low
4.73
Volume
(Below Average)
Volume:
3,020,312

10-day average volume:
3,395,399
3,020,312

Brooks to Participate in Stephens Annual Investment Conference

4:05 pm ET November 18, 2021 (PR Newswire) Print

Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Stephens Annual Investment Conference on Friday, December 3, 2021 which includes a webcast beginning at 1:00 p.m. CT. The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. A replay of the webcast will be available following the event.

About Brooks AutomationBrooks (Nasdaq: BRKS) is a leading provider of life sciences solutions worldwide. The Life Sciences business, recently rebranded as Azenta Life Sciences, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As announced at its recent investor day, Brooks Automation, Inc, currently trading on Nasdaq under the ticker symbol BRKS, is changing its name to Azenta, Inc. and will begin trading on Nasdaq under the ticker symbol AZTA, effective at the open of market trading on December 1, 2021.

In addition, the company operates the Semiconductor Solutions Group business, an industry-leading provider of semiconductor manufacturing automation and collaborative robotics solutions worldwide. On September 20, 2021, the Company announced the pending sale of this business to Thomas H. Lee Partners. Due to the pending divestiture, the Company began reporting the Semiconductor Solutions Group business as discontinued operations in its recent fiscal year-end earnings announcement.

Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.brooks.com and www.azenta.com.

INVESTOR CONTACTS:

Sara SilvermanDirector, Investor RelationsBrooks Automation 978.262.2635sara.silverman@brooks.com

Sherry DinsmoreBrooks Automation978.262.2400sherry.dinsmore@brooks.com

https://mma.prnewswire.com/media/653251/Brooks_Automation_Logo.jpg

https://c212.net/c/img/favicon.png?sn=NE82296&sd=2021-11-18

View original content to download multimedia:https://www.prnewswire.com/news-releases/brooks-to-participate-in-stephens-annual-investment-conference-301428587.html

SOURCE Brooks Automation

https://rt.prnewswire.com/rt.gif?NewsItemId=NE82296&Transmission_Id=202111181605PR_NEWS_USPR_____NE82296&DateId=20211118

comtex tracking

COMTEX_397220477/1005/2021-11-18T16:05:14

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.